Vallon Pharmaceuticals, Inc. Purchase Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement, dated as of August 22, 2023, by and between GRI Bio, Inc. and Aardvark Therapeutics, Inc
Purchase Agreements
Vallon Pharmaceuticals, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Vallon Pharmaceuticals, Inc.
2024
Form of Securities Purchase Agreement
Purchase Agreements
Vallon Pharmaceuticals, Inc.
2024
Form of Securities Purchase Agreement, dated as of February 1, 2024, between GRI Bio, Inc. and each purchaser named in the signature pages thereto
Purchase Agreements
Vallon Pharmaceuticals, Inc.
2024
Form of Securities Purchase Agreement
Purchase Agreements
Vallon Pharmaceuticals, Inc.
2024
Omnibus Amendment to Securities Purchase Agreements, dated February 17, 2023, by and among Vallon Pharmaceuticals, Inc., GRI Bio, Inc. and the investor party thereto
Purchase Agreements
Vallon Pharmaceuticals, Inc.
Pharmaceuticals
2023
Amendment No. 1 to Securities Purchase Agreement dated July 25, 2022
Purchase Agreements
Vallon Pharmaceuticals, Inc.
Pharmaceuticals
2022
Form of Securities Purchase Agreement
Purchase Agreements
Vallon Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Amended and Restated Asset Purchase Agreement, dated as of June 22, 2017, by and among Arcturus Therapeutics, Ltd. (and its subsidiary, Arcturus Therapeutics, Inc.), Amiservice...
Purchase Agreements
Vallon Pharmaceuticals, Inc.
Pharmaceuticals
CA
2021